Flagship’s AI unicorn Generate raises $273M Series C, as first drug in 17-program pipeline enters the clinic

Flagship Pioneering’s AI-focused startup Generate:Biomedicines has raised another megaround that will push multiple drug programs into the clinic.

The Somerville, MA-based biotech said Thursday it …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Flag­ship’s AI uni­corn Gen­er­ate rais­es $273M Se­ries C, as first drug in 17-pro­gram pipeline en­ters the clin­ic